$0.7583
-0.00270-0.35%
Pre-Market: 8:52 AM EDT
Comments
Loading...
Vincerx Pharma Earnings Estimates, EPS & Revenue | NASDAQ:VINC | Benzinga
Vincerx Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 12
EPS
$-3.400
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Vincerx Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Vincerx Pharma (VINC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-3.40 | $-4.40 | 22.7 % |
| Q2 | 2024-08-08 | $-1.00 | $-4.00 | 75.0 % |
| Q1 | 2024-05-14 | $-11.60 | $-5.80 | -100.0 % |
| Q4 | 2024-03-29 | $-4.60 | $-7.40 | 37.8 % |
Vincerx Pharma (VINC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Vincerx Pharma (NASDAQ:VINC) reporting earnings?
Vincerx Pharma (VINC) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Vincerx Pharma (NASDAQ:VINC)?
The Actual EPS was $-3.40, which beat the estimate of $-4.40.
What were Vincerx Pharma’s (NASDAQ:VINC) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.